Previous 10 | Next 10 |
2024-01-03 09:57:25 ET More on LianBio Johnson & Johnson inks licensing deal with LianBio (update) LianBio confirms buyout offer from Concentra Biosciences Seeking Alpha’s Quant Rating on LianBio Historical earnings data for LianBio Financi...
2023-12-31 01:55:00 ET Summary Elpiscience Biopharma forms a $1.7 billion collaboration with Astellas Pharma to develop a bispecific macrophage engager. AstraZeneca acquires Gracell Biotech in a deal worth up to $1.2 billion, including a clinical stage CAR-T therapy. Jinan Qil...
2023-12-26 03:50:07 ET More on LianBio LianBio confirms buyout offer from Concentra Biosciences LianBio receives buyout offer of $4.30 per share, plus CVR Financial information for LianBio For further details see: LianBio assigns rights for NBTXR3 in Chin...
SHANGHAI, China and PRINCETON, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that the company has entered into an agreement with Janssen Ph...
2023-12-20 08:10:26 ET More on LianBio LianBio confirms buyout offer from Concentra Biosciences LianBio receives buyout offer of $4.30 per share, plus CVR Seeking Alpha’s Quant Rating on LianBio For further details see: LianBio CEO Yizhe Wang resig...
SHANGHAI, China and PRINCETON, N.J., Dec. 20, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that Yi Larson, Chief Financial Officer, has resigned from LianBio ...
2023-12-19 16:18:46 ET More on LianBio LianBio confirms buyout offer from Concentra Biosciences LianBio receives buyout offer of $4.30 per share, plus CVR Seeking Alpha’s Quant Rating on LianBio Historical earnings data for LianBio Financial in...
SHANGHAI, China and PRINCETON, N.J., Dec. 19, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that Yizhe Wang, Ph.D., Chief Executive Officer has resigned from L...
SHANGHAI, China and PRINCETON, N.J., Dec. 06, 2023 (GLOBE NEWSWIRE) -- LianBio (NASDAQ: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that its Board of Directors (the “Board”) unanimously...
2023-12-03 04:30:00 ET Summary LianBio, a Princeton-Shanghai in-licensing company, received a $465 million buyout offer from Tang Capital Management. Perpetual Medicines, a Shanghai-Boston AI startup, closed an $8 million seed financing to advance its peptide drug discovery platfo...
News, Short Squeeze, Breakout and More Instantly...
LianBio Company Name:
LIAN Stock Symbol:
NASDAQ Market:
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...
A look at the top 10 most actives in the United States Grab Holdings Limited (GRAB) fell 0.2% to $3.235 on volume of 103,635,000 shares Better Therapeutics Inc. (BTTX) rose 108.6% to $0.073 on volume of 98,804,254 shares Verb Technology Company Inc. (VERB) rose 156.3% to $0.3639 on volume...
SHANGHAI, China and PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN) (“LianBio” or the “Company”), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that it ha...